CDTX logo

Cidara Therapeutics (CDTX) Accounts Receivable

Annual Accounts Receivable

$1.69 M
-$12.38 M-87.96%

December 1, 2024


Summary


Performance

CDTX Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCDTXbalance sheetmetrics:

Quarterly Accounts Receivable

$1.69 M
-$5000.00-0.29%

December 1, 2024


Summary


Performance

CDTX Quarterly Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCDTXbalance sheetmetrics:

Accounts Receivable Formula

Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales

CDTX Accounts Receivable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-88.0%0.0%
3 y3 years-68.4%-93.4%
5 y5 years+10000.0%-93.4%

CDTX Accounts Receivable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-88.0%at low-93.4%at low
5 y5-year-88.0%>+9999.0%-93.4%>+9999.0%
alltimeall time-88.0%>+9999.0%-93.4%-100.0%

Cidara Therapeutics Accounts Receivable History

DateAnnualQuarterly
Dec 2024
$1.69 M(-88.0%)
$1.69 M(-0.3%)
Sep 2024
-
$1.70 M(-27.7%)
Jun 2024
-
$2.35 M(-67.7%)
Mar 2024
-
$7.28 M(-48.3%)
Dec 2023
$14.07 M(+141.3%)
$14.07 M(+393.0%)
Sep 2023
-
$2.85 M(-47.9%)
Jun 2023
-
$5.48 M(-78.8%)
Mar 2023
-
$25.83 M(+342.8%)
Dec 2022
$5.83 M(+8.9%)
$5.83 M(+15.7%)
Sep 2022
-
$5.04 M(+4.3%)
Jun 2022
-
$4.83 M(-45.0%)
Mar 2022
-
$8.78 M(+64.0%)
Dec 2021
$5.36 M
$5.36 M(+38.3%)
Sep 2021
-
$3.87 M(+22.6%)
DateAnnualQuarterly
Jun 2021
-
$3.16 M(>+9900.0%)
Mar 2021
-
$11.00 K(-99.9%)
Dec 2020
$11.18 M(>+9900.0%)
$11.18 M(+71.4%)
Sep 2020
-
$6.52 M(+9.5%)
Jun 2020
-
$5.95 M(-5.6%)
Mar 2020
-
$6.31 M(>+9900.0%)
Dec 2019
$10.00 K(-99.6%)
$10.00 K(-99.6%)
Dec 2018
$2.57 M(+699.7%)
$2.57 M(>+9900.0%)
Sep 2018
-
$0.00(-100.0%)
Jun 2018
-
$41.00 K(-85.8%)
Mar 2018
-
$288.00 K(-10.3%)
Dec 2017
$321.00 K
$321.00 K(0.0%)
Sep 2017
-
$321.00 K(+49.3%)
Jun 2017
-
$215.00 K

FAQ

  • What is Cidara Therapeutics annual accounts receivable?
  • What is the all time high annual accounts receivable for Cidara Therapeutics?
  • What is Cidara Therapeutics annual accounts receivable year-on-year change?
  • What is Cidara Therapeutics quarterly accounts receivable?
  • What is the all time high quarterly accounts receivable for Cidara Therapeutics?
  • What is Cidara Therapeutics quarterly accounts receivable year-on-year change?

What is Cidara Therapeutics annual accounts receivable?

The current annual accounts receivable of CDTX is $1.69 M

What is the all time high annual accounts receivable for Cidara Therapeutics?

Cidara Therapeutics all-time high annual accounts receivable is $14.07 M

What is Cidara Therapeutics annual accounts receivable year-on-year change?

Over the past year, CDTX annual accounts receivable has changed by -$12.38 M (-87.96%)

What is Cidara Therapeutics quarterly accounts receivable?

The current quarterly accounts receivable of CDTX is $1.69 M

What is the all time high quarterly accounts receivable for Cidara Therapeutics?

Cidara Therapeutics all-time high quarterly accounts receivable is $25.83 M

What is Cidara Therapeutics quarterly accounts receivable year-on-year change?

Over the past year, CDTX quarterly accounts receivable has changed by $0.00 (0.00%)